摘要
Dermatologic TherapyVolume 35, Issue 11 e15851 LETTER Pustular psoriasis appearing in a Chinese woman treated with dupilumab for atopic dermatitis: A case report Xiaoyuan Zhong, Xiaoyuan Zhong Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYing Li, Ying Li orcid.org/0000-0002-4041-2646 Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYunlu Gao, Yunlu Gao Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYing Zhang, Ying Zhang Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorJiajing Lu, Jiajing Lu orcid.org/0000-0002-0827-0596 Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorNing Yu, Ning Yu Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYangfeng Ding, Yangfeng Ding Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYuling Shi, Corresponding Author Yuling Shi [email protected] orcid.org/0000-0002-1273-7881 Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, China Correspondence Yuling Shi, Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, No.1278, Baode Road, Jing'an District, Shanghai, China. Email: [email protected]Search for more papers by this author Xiaoyuan Zhong, Xiaoyuan Zhong Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYing Li, Ying Li orcid.org/0000-0002-4041-2646 Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYunlu Gao, Yunlu Gao Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYing Zhang, Ying Zhang Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorJiajing Lu, Jiajing Lu orcid.org/0000-0002-0827-0596 Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorNing Yu, Ning Yu Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYangfeng Ding, Yangfeng Ding Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, ChinaSearch for more papers by this authorYuling Shi, Corresponding Author Yuling Shi [email protected] orcid.org/0000-0002-1273-7881 Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, China Institute of Psoriasis, Tongji University School of Medicine, Shanghai, China Correspondence Yuling Shi, Department of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, No.1278, Baode Road, Jing'an District, Shanghai, China. Email: [email protected]Search for more papers by this author First published: 24 September 2022 https://doi.org/10.1111/dth.15851 Xiaoyuan Zhong, Ying Li, and Yunlu Gao have contributed equally to this work. Funding information: National Natural Science Foundation of China, Grant/Award Number: 81872522,82073429,82203913; Innovation Program of Shanghai Municipal Education Commission, Grant/Award Number: 2019-01-07-00-07-E00046; Clinical Research Plan of SHDC, Grant/Award Number: SHDC2020CR1014B,SHDC12018X06; Program of Shanghai Academic Research Leader, Grant/Award Number: 20XD1403300 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Harb H, Chatila TA. Mechanisms of Dupilumab. Clin Exp Allergy. 2020; 50(1): 5-14. 10.1111/cea.13491 CASPubMedWeb of Science®Google Scholar 2Halling AS, Loft N, Silverberg JI, Guttman-Yassky E, Thyssen JP. Real-world evidence of dupilumab efficacy and risk of adverse events: a systematic review and meta-analysis. J Am Acad Dermatol. 2021; 84(1): 139-147. 10.1016/j.jaad.2020.08.051 CASPubMedWeb of Science®Google Scholar 3Mirza FN, Wang A, Ramachandran SM, Damsky W, Cohen JM. Dupilumab-induced phenotype switch from atopic dermatitis to psoriasis is characterized by de novo interleukin-17A expression: a case report. Br J Dermatol. 2021; 185(2): 432-434. 10.1111/bjd.20064 CASPubMedWeb of Science®Google Scholar 4Stout M, Guitart J, Tan T, Silverberg JI. Psoriasis-like dermatitis developing in a patient with atopic dermatitis treated with dupilumab. Dermatitis. 2019; 30(6): 376-378. 10.1097/DER.0000000000000509 CASPubMedWeb of Science®Google Scholar 5Uppala R, Tsoi LC, Harms PW, et al. "Autoinflammatory psoriasis"-genetics and biology of pustular psoriasis. Cell Mol Immunol. 2021; 18(2): 307-317. 10.1038/s41423-020-0519-3 CASPubMedWeb of Science®Google Scholar 6Cohen JN, Bowman S, Laszik ZG, North JP. Clinicopathologic overlap of psoriasis, eczema, and psoriasiform dermatoses: a retrospective study of T helper type 2 and 17 subsets, interleukin 36, and β-defensin 2 in spongiotic psoriasiform dermatitis, sebopsoriasis, and tumor necrosis factor α inhibitor-associated dermatitis. J Am Acad Dermatol. 2020; 82(2): 430-439. 10.1016/j.jaad.2019.08.023 CASPubMedWeb of Science®Google Scholar 7Arakawa A, Vollmer S, Besgen P, et al. Unopposed IL-36 activity promotes clonal CD4(+) T-cell responses with IL-17A production in generalized pustular psoriasis. J Invest Dermatol. 2018; 138(6): 1338-1347. 10.1016/j.jid.2017.12.024 CASPubMedWeb of Science®Google Scholar 8Pfaff CM, Marquardt Y, Fietkau K, Baron JM, Lüscher B. The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and function. Sci Rep. 2017; 7(1): 15631. 10.1038/s41598-017-15892-7 PubMedWeb of Science®Google Scholar Volume35, Issue11November 2022e15851 ReferencesRelatedInformation